Tadalafil
NDC 69097-526, Tadalafil, tablet, film coated, from Cipla USA Inc..
- Product NDC
- 69097-526
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210255
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-526 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TADALAFIL20 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-526-03 | 69097052603 | 60 TABLET, FILM COATED in 1 BOTTLE (69097-526-03) |
| 69097-526-16 | 69097052616 | 4 TABLET, FILM COATED in 1 CARTON (69097-526-16) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cf6fc925-ad20-4ed0-9356-15d24afa8d0bNADAC price for package 69097052603
GET /v1/drugs/nadac/69097052603
Use it
Look up 69097-526 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-526 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-526. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.